Yari Ciani

4.7k total citations
27 papers, 1.4k citations indexed

About

Yari Ciani is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yari Ciani has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Yari Ciani's work include MicroRNA in disease regulation (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related molecular mechanisms research (4 papers). Yari Ciani is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related molecular mechanisms research (4 papers). Yari Ciani collaborates with scholars based in Italy, United States and Germany. Yari Ciani's co-authors include Silvano Piazza, Giannino Del Sal, Guidalberto Manfioletti, Riccardo Sgarra, Silvia Pegoraro, Dawid Walerych, Kamil Lisek, Francesca Demichelis, Gloria Ros and Antonio Rosato and has published in prestigious journals such as Nature Communications, Bioinformatics and PLoS ONE.

In The Last Decade

Yari Ciani

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yari Ciani Italy 18 933 482 394 213 134 27 1.4k
Ronald W. Stam Netherlands 26 1.6k 1.7× 342 0.7× 502 1.3× 117 0.5× 50 0.4× 75 2.7k
Véronique Secq France 15 448 0.5× 251 0.5× 431 1.1× 177 0.8× 46 0.3× 41 1.1k
Yulian Niu Canada 18 787 0.8× 346 0.7× 310 0.8× 100 0.5× 58 0.4× 20 1.2k
Jiadong Wang China 25 1.3k 1.4× 224 0.5× 529 1.3× 132 0.6× 61 0.5× 57 1.7k
S. John Weroha United States 21 741 0.8× 368 0.8× 610 1.5× 174 0.8× 27 0.2× 71 1.5k
Xiangcang Ye United States 19 975 1.0× 468 1.0× 675 1.7× 187 0.9× 53 0.4× 26 1.5k
Yuanzhong Wu China 21 1.3k 1.4× 544 1.1× 262 0.7× 164 0.8× 37 0.3× 50 1.6k
Harold Hatch United States 7 1.1k 1.1× 165 0.3× 346 0.9× 277 1.3× 75 0.6× 7 1.4k
Jieqing Chen China 16 602 0.6× 371 0.8× 532 1.4× 171 0.8× 46 0.3× 42 1.3k
Guanhua Song China 19 829 0.9× 386 0.8× 284 0.7× 116 0.5× 80 0.6× 43 1.4k

Countries citing papers authored by Yari Ciani

Since Specialization
Citations

This map shows the geographic impact of Yari Ciani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yari Ciani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yari Ciani more than expected).

Fields of papers citing papers by Yari Ciani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yari Ciani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yari Ciani. The network helps show where Yari Ciani may publish in the future.

Co-authorship network of co-authors of Yari Ciani

This figure shows the co-authorship network connecting the top 25 collaborators of Yari Ciani. A scholar is included among the top collaborators of Yari Ciani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yari Ciani. Yari Ciani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lago, Sara, Vittoria Poli, Alice Turdo, et al.. (2025). ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent transcription replication conflicts in triple negative breast cancer. Nature Communications. 16(1). 4602–4602. 1 indexed citations
2.
Gasperini, Paola, et al.. (2025). PRODE recovers essential and context-essential genes through neighborhood-informed scores. Genome biology. 26(1). 42–42.
3.
Ciani, Yari, et al.. (2021). Circulating RNAs in prostate cancer patients. Cancer Letters. 524. 57–69. 60 indexed citations
4.
Fedrizzi, Tarcisio, et al.. (2021). Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations. Computational and Structural Biotechnology Journal. 19. 4394–4403. 5 indexed citations
5.
Ciani, Yari, Tarcisio Fedrizzi, Davide Prandi, et al.. (2021). Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer. Cell Systems. 13(2). 183–193.e7. 18 indexed citations
6.
Nienhold, Ronny, Yari Ciani, Viktor H. Koelzer, et al.. (2020). Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nature Communications. 11(1). 5086–5086. 171 indexed citations
7.
Cotella, Diego, Maria Felicia Soluri, Francesco Raspagliesi, et al.. (2019). High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids. OncoImmunology. 8(9). e1614856–e1614856. 27 indexed citations
8.
Pegoraro, Silvia, Gloria Ros, Yari Ciani, et al.. (2019). HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1. Journal of Experimental & Clinical Cancer Research. 38(1). 313–313. 58 indexed citations
9.
Antoniali, Giulia, Lisa Lirussi, Mikiei Tanaka, et al.. (2017). Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. Nature Communications. 8(1). 797–797. 96 indexed citations
10.
Franchin, Cinzia, Silvia Pegoraro, Yari Ciani, et al.. (2017). HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells. Scientific Reports. 7(1). 11768–11768. 28 indexed citations
11.
Piazza, Silvano, Stefania Marzinotto, Yari Ciani, et al.. (2017). OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness. Oncogene. 36(30). 4253–4266. 35 indexed citations
13.
Agostoni, Elena, Alisia Carnemolla, Yari Ciani, et al.. (2016). Effects of Pin1 Loss in HdhQ111 Knock-in Mice. Frontiers in Cellular Neuroscience. 10. 110–110. 13 indexed citations
14.
Walerych, Dawid, Kamil Lisek, Roberta Sommaggio, et al.. (2016). Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nature Cell Biology. 18(8). 897–909. 185 indexed citations
15.
Rustighi, Alessandra, et al.. (2016). PIN1 in breast development and cancer: a clinical perspective. Cell Death and Differentiation. 24(2). 200–211. 34 indexed citations
16.
Wiśniewski, Jacek R., Yari Ciani, Angela Amato, et al.. (2015). Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer. Molecular & Cellular Proteomics. 15(1). 109–123. 31 indexed citations
17.
Pegoraro, Silvia, Gloria Ros, Yari Ciani, et al.. (2015). A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness. Oncotarget. 6(22). 19087–19101. 56 indexed citations
18.
Verardo, Roberto, Silvano Piazza, Yari Ciani, et al.. (2014). Specific Mesothelial Signature Marks the Heterogeneity of Mesenchymal Stem Cells From High-Grade Serous Ovarian Cancer. Stem Cells. 32(11). 2998–3011. 13 indexed citations
19.
Pegoraro, Silvia, Gloria Ros, Silvano Piazza, et al.. (2013). HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget. 4(8). 1293–1308. 112 indexed citations
20.
Widlund, Per O., Silvano Piazza, Débora Rosa Bublik, et al.. (2012). GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration. PLoS ONE. 7(12). e51259–e51259. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026